@article{ec6e112864ff49fd89ff609d169e754e,
title = "Pharmacological management of treatment-resistant pediatric depression",
author = "Kratochvil, {Christopher J.} and Wagner, {Karen Dineen} and Graham Emslie and John March",
note = "Funding Information: Disclosure: Dr. Kratochvil has received grant support from and is a consultant to and/or member of the speaker's bureau of Eli Lilly and Co., GlaxoSmithKline, Forest, Cephalon, Novartis, McNeil, Organon, Bristol-Myers Squibb, and AstraZeneca. Dr. Wagner has received grant support from and is a consultant to and/or member of the speaker's bureau of Abbott Laboratories, Bristol-Myers Squibb, Cyberonics, Eli Lilly and Co., Forest Laboratories, GlaxoSmith Kline, Janssen, Jazz Pharmaceuticals, Novartis, Organon, Ortho-MacNeil, Otsuka, Pfizer Inc., UCB Pharma, and Wyeth-Ayerst. Dr. Emslie has received grant support from and is a consultant to and/or member of the speaker's bureau of Eli Lilly and Co., Organon, Inc., RepliGen, GlaxoSmithKline, Forest Laboratories, Inc., Pfizer, Inc., Wyeth-Ayerst, and McNeil. Dr. March has received grant support from and is a consultant to and/or member of the speaker's bureau of Shire, Eli Lilly and Co., Organon, Pfizer, Wyeth, AstraZeneca, and GlaxoSmithKline. ",
year = "2005",
month = feb,
doi = "10.1097/00004583-200502000-00013",
language = "English (US)",
volume = "44",
pages = "198--200",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "2",
}